Einige Inhalte dieser Seite sind nur für Abonnenten sichtbar.       Anmelden     oder      Jetzt abonnieren!

Archiv: Unternehmen

Galderma shareholders approve all Annual General Meeting proposals » Galderma
UBS statement on regulatory capital announcements made by Swiss government » Report
Too-Big-To-Fail-Regulierung: Bundesrat verabschiedet Botschaft und Eigenmittelverordnung » Report
Nescafé Espresso Concentrate expands across Europe, entering ten new markets » Report
Bundesrat prüft Massnahmen zur Beschleunigung des Wohnungsbaus » Report
LLB now with Aa1 deposit rating from Moody’s » Report
LLB neu mit Aa1 Depositenrating von Moody's » Report
Montana Aerospace AG: Bekanntgabe des Rücktritts des Chief Executive Officer » Report
Montana Aerospace announces resignation of Chief Executive Officer » Report
Phoenix Mecano gets off to a strong start in 2026 » Report
Phoenix Mecano mit starkem Start ins 2026 » Report
BioVersys completes BV100 Phase 1 clinical trial in China » Report
ABB Ltd Ergebnis des 1. Quartals 2026 » Report
ABB Ltd: Q1 2026 results » Report
Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS » Report
Roche's fenebrutinib significantly reduced relapses versus standard of care to approximately one every 17 years in RMS » Report
Genentech’s Enspryng (Satralizumab) Reduces Risk of Relapses by 68% Demonstrating Potential to Become First Treatment for MOGAD » Report
Bystronic AG : Annual General Meeting 2026 » Report
Bystronic AG : Ordentliche Generalversammlung 2026 » Report
Annual General Meeting of Galenica Ltd. passes all motions and approves dividend of CHF 2.50 per share » Report